A detailed history of Israel Englander (Millennium Management LLC) transactions in Vaccitech PLC stock. As of the latest transaction made, Millennium Management LLC holds 10,148 shares of VACC stock, worth $34,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,148
Holding current value
$34,604
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
10,148 New
10,148 $34,000
Q1 2023

May 15, 2023

BUY
$2.16 - $3.15 $3,363 - $4,904
1,557 Added 3.86%
41,945 $94,000
Q4 2022

Feb 14, 2023

BUY
$2.1 - $2.68 $20,930 - $26,711
9,967 Added 32.76%
40,388 $97,000
Q3 2022

Nov 14, 2022

SELL
$3.06 - $6.19 $94,780 - $191,729
-30,974 Reduced 50.45%
30,421 $96,000

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.